Stockreport

Novartis to conduct hydroxychloroquine trial for hospitalized COVID-19 patients [MarketWatch]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF Novartis said it will proceed with a Phase III clinical trial of hydroxychloroquine in hospitalized patients with COVID-19 disease. The trial will be of approximately 44 [Read more]